🟢 Tenax Therapeutics is trading 5.6% up today amid broader biotech-sector strength

Tenax Therapeutics is trading at $1.60, up 5.59%, with broader biotech-sector strength offering a possible tailwind.

• No verified company-specific announcement was identified for October 20, 2026.
• The biotech ETF XBI was up 2.10%, amid industry M&A activity and positive clinical-trial news. Merck KGaA’s announced acquisition of Silence Therapeutics is one example.
• This sector context is plausible but does not establish the precise cause of Tenax Therapeutics’ move.